Skip to content
2000
Volume 12, Issue 2
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Alzheimer's disease (AD) is a multi factorial disease, related to the loss of neurons and synapses in cerebral cortex and subcortical structures, leading to degenerative changes and atrophy. Despite abundance of facts related to AD and its pathology, the only drugs used in the prevention and treatment are those from the cholinesterase inhibitors group. However, there is growing evidence that a non-classical therapeutic approach in the treatment of AD has beneficial effects. In this review we summarized recent literature data related to the non-classical drugs for the treatment of AD predominantly used in clinical testing, such as amyloid aggregation inhibitors, beta-sheet breakers, antioxidants, estrogens and immunotherapeutics.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180811666140909010803
2015-02-01
2025-06-18
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180811666140909010803
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test